A review of policy actions implemented during a toxic drug public health emergency in British Columbia, Canada (2016–2024)

Opioid agonist therapy discontinuation in British Columbia: A cross-sectional study of people who access harm reduction services

10.1136/bmjopen-2024-090704 · doi-reference

Public support for harm reduction: A population survey of Canadian adults

10.1371/journal.pone.0251860 · doi-reference

Access and barriers to safer supply prescribing during a toxic drug emergency: A mixed methods study of implementation in British Columbia, Canada

10.1186/s13011-024-00625-7 · doi-reference

A qualitative study exploring how young people perceive and experience substance use services in British Columbia, Canada

10.1186/s13011-022-00456-4 · doi-reference

Trajectories of retention in opioid agonist therapy in a Canadian setting

10.1016/j.drugpo.2020.102696 · doi-reference

"Everything is not right anymore": Buprenorphine experiences in an era of illicit fentanyl

10.1016/j.drugpo.2019.09.003 · doi-reference

How should harm reduction be included in care continua for patients with opioid use disorder?

10.1001/amajethics.2024.562 · doi-reference

The increase in benzodiazepine-laced drugs and related risks in Canada: The urgent need for effective and sustainable solutions

10.1016/j.drugpo.2022.103933 · doi-reference

Population perinatal substance use and an environmental scan of health services in British Columbia, Canada

10.1016/j.drugalcdep.2024.112457 · doi-reference

Implementation of pharmaceutical alternatives to a toxic drug supply in British Columbia: A mixed methods study

10.1016/j.josat.2024.209341 · doi-reference

Bed-based care as a response to the overdose crisis: An approach to informing and evaluating proposed expansion

10.1503/cmaj.240955 · doi-reference

Public support for safer supply programs: Analysis of a cross-sectional survey of Canadians in two provinces

10.17269/s41997-022-00736-3 · doi-reference

A systematic review of stakeholder perceptions of supervised injection facilities

10.1016/j.drugalcdep.2019.02.006 · doi-reference

Public support of and attitudes toward decriminalization of possession of illegal drugs among the general population in British Columbia

10.1186/s13011-025-00680-8 · doi-reference

The impact of the novel coronavirus disease (COVID-19) pandemic on drug overdose-related deaths in the United States and Canada: A systematic review of observational studies and analysis of public health surveillance data

10.1186/s13011-021-00423-5 · doi-reference

The short-term impacts of decriminalisation of personal possession of select illegal drugs on drug poisonings in British Columbia, Canada (2015–2023)

10.1111/dar.70036 · doi-reference

'I'm on the coast and I'm on methadone': A qualitative study examining access to opioid agonist treatment in rural and coastal British Columbia

10.4103/cjrm.cjrm_56_23 · doi-reference

"It's just a perfect storm": Exploring the consequences of the COVID-19 pandemic on overdose risk in British Columbia from the perspectives of people who use substances

10.1186/s12889-023-15474-5 · doi-reference

Addressing racial and ethnic inequities in opioid overdose mortality: Strategies for equitable interventions and structural change

10.1007/s11920-024-01556-7 · doi-reference

Understanding risk and protective factors associated with opioid misuse among at-risk adolescents and young adults in the emergency department

10.1016/j.drugalcdep.2025.112814 · doi-reference

Responding to changes in the unregulated drug supply: The need for a dynamic approach to drug checking technologies

10.1080/00952990.2023.2226312 · doi-reference

Evaluating complex transformation: British Columbia’s provincial response to the overdose public health emergency

10.1108/jhom-05-2019-0139 · doi-reference

Implementing Foundry: A cohort study describing the regional and virtual expansion of a youth integrated service in British Columbia, Canada

10.1111/eip.13538 · doi-reference

Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada

10.1016/j.drugpo.2021.103237 · doi-reference